Remove 2030 Remove Communication Remove Documentation
article thumbnail

STAT+: Generative AI is transforming radiology, and it’s only the beginning

STAT

By 2030, agreed a roomful of radiologists in Chicago this week, generative AI will be ubiquitous in their written work.  Products using LLMs to streamline radiology documentation dominated the demonstration hall, and several sessions centered on health technology’s latest poster child. 

article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. billion Global concerns surrounding PFAS, or per- and polyfluoroalkyl substances, are due to their well-documented effects on human health and the environment. There is worldwide concern around the use of PFAS.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How ICH E6 (R3) is changing clinical trials

Pharmaceutical Technology

Integrated CDMS solutions also facilitate smoother communication and coordination between stakeholders, enabling faster, data-driven decision-making – all increasingly crucial for maintaining oversight and regulatory compliance. To explore how Zelta can support your organization’s clinical data management needs, download the document below.

article thumbnail

Meet Sofiya, Mount Sinai’s latest AI assistant

Beckers Hospital Review

The new pre-procedure coordination assistant at New York City-based Mount Sinai Hospital’s cardiac catheterization lab may not be human, but she knows how to communicate like one. Projections from various government agencies indicate that by 2030, this shortage will worsen. “She has a soft, calm voice.

article thumbnail

Top 10 RPM Vendors 2025: Driving Results in Remote Patient Monitoring

PharmD Live

RPM investments projected to exceed $29 billion by 2030 , healthcare executives are demanding clinically validated solutions that streamline billing and maintain unwavering CMS alignment. Is your Remote Patient Monitoring (RPM) program delivering measurable clinical outcomes, audit-ready compliance, and scalable ROI?

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn. of the global sales total.

article thumbnail

7 leaders on how EHRs must evolve by 2030

Beckers Hospital Review

Care coordination at scale: We assess whether the platform supports care coordination across different settings, featuring shared care plans, intelligent task management, and communication tools that function across teams and care environments. We need tools to reduce the burden of documentation for our clinical teams.